Annals of Emergency Medicine
Volume 44, Issue 4 , Pages 401-406 , October 2004

Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death

  • Benoit Bailey, MD, MSc

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Benoit Bailey, MD, MSc, Department of Pediatrics, Hôpital Ste. Justine, 3175 Chemin Côte Ste-Catherine, Montréal, Québec, H3T 1C5 Canada; 514-345-4931 ext. 6276, fax 514-345-4823;
    • ,
  • René Blais, MD
    • ,
  • Anne Letarte, BSc

Received 12 March 2004 ,Revised 18 May 2004 ,Accepted 20 May 2004.

References 

  1. Meredith TJ, Jacobsen D, Haines JA, et al. Antidotes for Poisoning by Paracetamol. Cambridge, United Kingdom: Cambridge Press; 1995;
  2. Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Tox Clin Toxicol. 1998;36:277–285
  3. Buckley NA, Whyte IM, O'Connell DL, et al. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen poisoning. J Tox Clin Toxicol. 1999;37:759–767
  4. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med. 1998;31:710–715
  5. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust. 1989;150:329–331
  6. Chan TY, Critchley JA. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol. 1994;13:542–544
  7. Kao LW, Kirk MA, Furbee RB, et al. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?. Ann Emerg Med. 2003;42:741–750
  8. Miller LF, Rumack BH. Clinical safety of high oral doses of acetylcysteine. Semin Oncol. 1983;10(Suppl 1):76–85
  9. Mant T, Tempowski JH, Volans GN, et al. Adverse reactions to acetylcysteine and effects of overdose. BMJ. 1984;289:217–219
  10. Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol. 2001;51:87–91
  11. Lorentzen H, Glenthøj J, Olesen T. N-acetylcysteine overdosage after insignificant acetaminophen intake. [letter] Acta Paediatr. 2002;91:984–985
  12. Anonymous . Death after N-acetylcysteine. [letter] Lancet. 1984;i:1421
  13. Sunman W, Hughes AD, Sever PS. Anaphylactoid response to intravenous acetylcysteine. [letter] Lancet. 1992;339:1231–1232
  14. Appelboam AV, Dargan PI, Knighton J. Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma. Emerg Med J. 2002;19:594–595
  15. Donovan JW, Proudfoot AT, Prescott LF. Adverse effects of intravenous N-acetylcysteine. [abstract] Vet Hum Toxicol. 1986;28:487
  16. Centre Anti-poison du Québec . Les Antidotes en Toxicologie d'Urgence. Quebec, Canada: Centre Anti-poison du Québec; 1997;
  17. Hershkovitz E, Shorer Z, Levitas A, et al. Status epilepticus following intravenous N-acetylcysteine therapy. Isr J Med Sci. 1996;32:1102–1104
  18. Simonart T, Tukendhaft P, Verecken P, et al. Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant-induced hypersensitivity syndrome. [letter] Br J Dermatol. 1998;138:553
  19. Johnston RE, Hawkins HC, Weikel JHJ. The toxicity of N-acetylcysteine in laboratory animals. Semin Oncol. 1983;10(Suppl 1):17–24
  20. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41(Suppl 2):S23–S30
  21. Towne AR, Pellock JM, Boggs JG, et al. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34
  22. Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Ped Clin North Am. 2001;48:683–694
  23. Meldrum BS, Brierly JB. Prolonged epileptic seizures in primates. Arch Neurol. 1973;28:10–17
  24. Tasker RC, Dean JM. Status epilepticus. In:  Rogers MC,  Nichols DG editor. Textbook of Pediatric Intensive Care. Baltimore, MD: Williams and Wilkins; 1996;p. 747–777
  25. Gastaut H. Classification of status epilepticus. In:  Delgado-Escueta AV,  Wasterlain CG,  Treiman DM, et al. editor. Advances in Neurology;. Status Epilepticus: Mechanisms of Brain Damage and Treatment. vol. 34:New York, NY: Raven Press; 1983;p. 15
  26. Venturelli J, Tein I, Hollenberg R. Increased intracranial pressure associated with N-acetylcysteine inhalation therapy. [letter] Crit Care Med. 1984;12:926–927
  27. Ferner RE, Langford NJ, Anton C, et al. Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol. 2001;52:573–577
  28. Centre Anti-poison du Québec . Les Antidotes en Toxicologie d'Urgence. 2e édition. Quebec, Canada: Centre Anti-poison du Québec; 2002;
  29. Potts AL, Barr FE, Gregory DF, et al. Computerized physician order entry and medication errors in a pediatric critical care unit. Pediatrics. 2004;113:59–63
  30. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety. Arch Intern Med. 2003;163:1409–1416
  31. Kirk M, Selden B, Kulig K. Serum N-acetylcysteine levels during hemodialysis. [abstract] Vet Hum Toxicol. 1992;34:327

 The authors report this study did not receive any outside funding or support.

 Reprints not available from the authors.

PII: S0196-0644(04)00545-1

doi: 10.1016/j.annemergmed.2004.05.014

Annals of Emergency Medicine
Volume 44, Issue 4 , Pages 401-406 , October 2004

Article Tools